Pharmaceutical Drug Names Follow INN and WHO Guidelines, Analysis Finds

Pharmaceutical drug names involve a complex system that balances creativity and regulatory compliance, according to a recent analysis. The process follows guidelines from organizations such as the International Nonproprietary Names (INN) system and the World Health Organization (WHO). The analysis explores the history, rules, and established best practices used in the pharmaceutical industry for naming drugs. The naming conventions utilize strategic prefixes, suffixes, and root words, the analysis notes. These components help create unique and descriptive names for medications. The article also refers the reader to an in-depth guide on the science and art of pharmaceutical drug naming.

Newsflash | Powered by GeneOnline AI
Date: April 15, 2025

Related posts:

FDA Approves Pfizer/BioNTech’s COVID-19 Vaccine for 5- to 11-Year-Olds Generic Drug Demand Soars in Emerging Markets Amid Growing Healthcare Needs Patient Engagement Platforms Help Pharma Companies Maintain Brand Value Post-Patent Expiration Guide Explores Drug Pricing, Highlights Patent Expirations’ Impact

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後